News
Cimeio Therapeutics Presents SCIP Platform Proof-of-Concept Data at ASH
Cimeio Therapeutics today announced the U.S. Patent Office has issued a key patent covering the company’s Shielded-Cell & Immunotherapy Pairs (SCIP) platform.
Cimeio Therapeutics Announces Issuance of Key Patent Covering Cell Therapy Platform
Cimeio Therapeutics today announced the U.S. Patent Office has issued a key patent covering the company’s Shielded-Cell & Immunotherapy Pairs (SCIP) platform.
Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline
Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies.
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A
Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies.